Title |
Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation
|
---|---|
Published in |
Implementation Science, November 2012
|
DOI | 10.1186/1748-5908-7-116 |
Pubmed ID | |
Authors |
Gabriel R. Galindo, J. J. Garrett-Walker, Patrick Hazelton, Tim Lane, Wayne T. Steward, Stephen F. Morin, Emily A. Arnold |
Abstract |
An international randomized clinical trial (RCT) on pre-exposure prophylaxis (PrEP) as an human immunodeficiency virus (HIV)-prevention intervention found that taken on a daily basis, PrEP was safe and effective among men who have sex with men (MSM) and male-to-female transgender women. Within the context of the HIV epidemic in the United States (US), MSM and transgender women are the most appropriate groups to target for PrEP implementation at the population level; however, their perspectives on evidenced-based biomedical research and the results of this large trial remain virtually unknown. In this study, we examined the acceptability of individual daily use of PrEP and assessed potential barriers to community uptake. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 2% |
United Kingdom | 2 | 1% |
Unknown | 189 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 38 | 20% |
Student > Master | 27 | 14% |
Student > Ph. D. Student | 24 | 12% |
Student > Doctoral Student | 21 | 11% |
Student > Bachelor | 13 | 7% |
Other | 36 | 19% |
Unknown | 35 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 50 | 26% |
Social Sciences | 38 | 20% |
Psychology | 26 | 13% |
Nursing and Health Professions | 14 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
Other | 15 | 8% |
Unknown | 46 | 24% |